SØren Lemonius
DIRECTOR
Biopharmaceuticals
Nuevolution
Denmark
Biography
Mr. Lemonius is one of three founding Life Science Partners at Sunstone Capital and has previously spent 10+ years in corporate management. During five years as CTO at Danionics, he participated in developing the company from a 30-employee technology company to a €27+ million, 300+ employees, product selling, listed company. He was responsible for releasing three new product generations. Before joining Danionics, Søren was Innovation Manager at FOSS Analytical, a private, €130+ million developer and producer of analytical equipment. Søren currently also serves on the boards of Eurodiagnostica AB, Galecto Biotech AB A/S and is an observer at the Board of Symphogen A/S.
Research Interest
Focusing on delivering breakthrough medicines for treatment of cancer and inflammatory diseases
